pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 1
    GRC-39815
    Chronic Obstructive Pulmonary Disease (COPD) Glenmark Pharmaceuticals Ltd
  • Phase 2
    GRC-54276
    Bile Duct Cancer (Cholangiocarcinoma) Ichnos Glenmark Innovation
  • Phase 2
    GRF-312
    Keratoconjunctivitis Sicca (Dry Eye)$GRFS Grifols SA
  • Preclinical
← prev
page 89 of 231
next →
131
Pain89
Neurology1
GRI-0803
Systemic Lupus Erythematosus
$GRI GRI Bio, Inc.
  • Phase 1
    GRN-300
    Triple-Negative Breast Cancer (TNBC) Greenfire Bio LLC
  • Phase 2
    GS-030
    Retinitis Pigmentosa (Retinitis) GenSight Biologics SA
  • Phase 1
    GS-0321
    Solid Tumor$GILD GILEAD SCIENCES, INC.
  • Phase 3
    GS-100
    no indication Grace Science LLC
  • Phase 1
    GS-6791
    Rheumatoid Arthritis$GILD GILEAD SCIENCES, INC.
  • Phase 2
    GSK-101
    Human Epidermal Growth Factor Receptor 2 Low Breast Cance…$GSK GSK plc
  • Phase 2
    GSK-4382276A
    Seasonal Influenza$GSK GSK plc
  • Phase 2
    GSK-5536522
    Influenza A Virus, H5N1 Subtype Infections$GSK GSK plc
  • Phase 1
    GT-01
    Obesity Gila Therapeutics Inc
  • Phase 1
    GTB-3650
    Myelodysplastic Syndrome (Preleukemia)$GTBP GT Biopharma, Inc.
  • Phase 1
    GTB-5550
    Epithelial Ovarian Cancer$GTBP GT Biopharma, Inc.
  • Preclinical
    GTC-3295
    Alzheimer's Disease Gismo Therapeutics Inc
  • GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE
    GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE
    no indication RB HLTH
  • GUANFACINE
    GUANFACINE
    no indication UNICHEM
  • Phase 2
    GV-200251
    Cervical Cancer GV20 Therapeutics LLC
  • Preclinical
    GW-01
    Unspecified Cancer Groovy Medicine Inc
  • Preclinical
    GXC-301
    Lafora Disease (Unverricht Disease) Genixcure Inc
  • Preclinical
    GXV-002
    Pulmonary Arterial Hypertension GEXVal Inc
  • Phase 1
    Gallium Maltolate
    Recurrent Glioblastoma Multiforme (GBM)$KMCM Titan Holdings Corp.
  • Preclinical
    Gene Therapies to Activate NAGLU for Mucopolysaccharidosis Type IIIB
    Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) Neurogt Inc
  • Preclinical
    Gene Therapy Product
    Chemotherapy Induced Peripheral Neuropathy Navega Therapeutics Inc
  • Preclinical
    Gene Therapy for Alpha-Mannosidosis
    Alpha-Mannosidosis Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • Preclinical
    Gene Therapy for Arginase 1 Deficiency
    Hyperargininemia (Arginase I Deficiency) UCLA Health System
  • Preclinical
    Gene Therapy for Bone Fracture
    Bone Fracture Cedars-Sinai Medical Center
  • Preclinical
    Gene Therapy for Branched-Chain 2-Ketoacid Dehydrogenase Deficiency
    Maple Syrup Urine Disease Clinic for Special Children
  • Preclinical
    Gene Therapy for Limb-Girdle Muscular Dystrophy Type 2C/R5
    Limb-Girdle Muscular Dystrophy Evolyra Therapeutics